Positive phase III results for Nuvo osteoarthritis patch
Pennsaid is currently approved for sale in Canada and several European countries. The phase III trial, named Study 112, was designed with the advice and recommendations provided by
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.